Garda Capital Partners’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-800
Closed -$250K 477
2025
Q2
$250K Sell
800
-17,300
-96% -$6.61M 0.01% 524
2025
Q1
$9.48M Buy
+18,100
New +$9.25M 0.24% 115
2024
Q4
Sell
-18,100
Closed -$10.6M 499
2024
Q3
$10.6M Buy
18,100
+9,800
+118% +$5.54M 0.3% 96
2024
Q2
$4.23M Sell
8,300
-4,700
-36% -$2.3M 0.15% 178
2024
Q1
$6.43M Buy
13,000
+10,000
+333% +$5.08M 0.27% 114
2023
Q4
$1.58M Hold
3,000
0.14% 170
2023
Q3
$1.51M Buy
3,000
+1,000
+50% +$492K 0.07% 274
2023
Q2
$961K Hold
2,000
0.05% 247
2023
Q1
$945K Sell
2,000
-13,500
-87% -$6.51M 0.05% 244
2022
Q4
$8.22M Buy
+15,500
New +$8.21M 0.45% 49

Other funds holding UNH

Garda Capital Partners's UNH Position: Q1 2024 in Review

Garda Capital Partners sold out of UnitedHealth (UNH) in Q1 2024, closing a stake of 865 shares — an estimated $440K sold.

Garda Capital Partners first reported a position in UNH in Q4 2022 and held it in 5 quarters. The position peaked at $1.59M in Q4 2022. 3,374 funds tracked by Wall St. Rank hold UNH as of Q1 2024.

  • Garda Capital Partners reported no remaining UnitedHealth position as of Q1 2024 after selling out during the quarter.
  • Garda Capital Partners sold 865 UnitedHealth shares in Q1 2024, an estimated $440K.
  • Garda Capital Partners first reported a position in UnitedHealth in Q4 2022 and held it in 5 quarters.
  • Garda Capital Partners's UnitedHealth position peaked at $1.59M in Q4 2022.
  • 3,374 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2024.

Based on Garda Capital Partners's 13F filing for Q1 2024, filed 14 May 2024.